3.Significance of Oct-4's expression in thyroid neoplasm.
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2010;24(15):682-685
OBJECTIVE:
To discuss the meanings of Oct-4's expression in thyroid adenoma, thyroid papillary carcinoma, thyroid follicular carcinoma, and medullary thyroid carcinoma.
METHOD:
We examined the expression of Oct-4 in 15 thyroid adenoma, 30 thyroid papillary carcinomas, 2 thyroid follicular carcinomas, and 3 medullary thyroid carcinomas using immunofluorescence.
RESULT:
Oct-4 expression was observed in all the thyroid-related diseases mentioned above. In thyroid papillary carcinomas, the expression of Oct-4 were higher than that in thyroid adenoma, and had no obvious relationship with the patients age, sex, the size and location of tumor and tumor metastasis.
CONCLUSION
The formation of the thyroid carcinomas may be concerned with the stem cells in thyroid. There are more stem cells in medullary thyroid carcinomas and follicular carcinomas.
Adenocarcinoma, Follicular
;
metabolism
;
pathology
;
Carcinoma, Neuroendocrine
;
Carcinoma, Papillary
;
metabolism
;
pathology
;
Humans
;
Octamer Transcription Factor-3
;
metabolism
;
Thyroid Neoplasms
;
metabolism
;
pathology
4.Expression of annexin I in different histological types of carcinomas.
Li-Yan XUE ; Liang-Hong TENG ; Shuang-Mei ZOU ; Li-Qun REN ; Shan ZHENG ; Wei LUO ; Rui BI ; Ning LÜ
Chinese Journal of Oncology 2007;29(6):444-448
OBJECTIVETo investigate the expression of annexin I in esophageal squamous cell carcinoma (SCC) and carcinomas of other histological types in order to analyze the correlation between the expression of annexin I and carcinogenesis.
METHODSFirst, a set of tissue microarray was established, which consisted of SCC from the esophagus (208 cases), lung, larynx, cervix, and external genital organs; adenocarcinomas from the lung, stomach, colon and rectum, liver, pancreas, breast, thyroid and kidney with 30 cases in each group, meanwhile, the corresponding normal tissue was also obtained for control. Immunohistochemistry was used to detect the expression of annexin I in different types of carcinomas and the corresponding normal controls from different organs. The correlation between the expression of annexin I and the clinicopathological feature was analyzed and compared, which included age, gender, differentiation grade and lymph node metastasis.
RESULTSIt was found that the expression of annexin I was decreased in esophageal SCC, when compared with normal esophageal squamous epithelia (P < 0.001), the similarity was also found in SCC of the lung, larynx and cervix. However, though negative in normal epidermis, annexin I expression was detected in some cases with SCC from external genital organs. Annexin I was found to be overexpressed in adenocarcinomas of the lung, stomach, colon and rectum, liver, pancreas, breast, thyroid and kidney, particularly very strong expression of annexin I was seen in lung adenocarcinoma, uterine endometrioid adenocarcinoma and ovarian serous adenocarcinoma. Interestingly, it was found to be positive in all thyroid papillary carcinomas, but negative in all normal thyroid glands. However, annexin I expression was found to be negative in all hepatocellular carcinoma and normal hepatocytes; and it was only detected in myoepithelium of normal breast tissue, but not in ductal luminal cells, and rarely in infiltrating ductal adenocarcinoma. In SCC, annexin I expression was stronger in well differentiated ones than that in the poorly differentiated ones. However, contrasting with SCC, in the adenocarcinomas from different organs, annexin I expression was much stronger in poorly differentiated ones than that in the well differentiate ones, especially in the adenocarcinomas from stomach, colon and rectum, pancreas, ovarian and kidney.
CONCLUSIONAnnexin I expression is quite different among different types of carcinomas, and is correlated with histopathological type and differentiation grade. Further study is needed to investigate its role in the carcinogenesis.
Adenocarcinoma ; metabolism ; pathology ; Annexin A1 ; metabolism ; Carcinoma, Endometrioid ; metabolism ; pathology ; Carcinoma, Squamous Cell ; metabolism ; pathology ; Cell Differentiation ; Endometrial Neoplasms ; metabolism ; pathology ; Epithelium ; metabolism ; Esophageal Neoplasms ; metabolism ; pathology ; Esophagus ; metabolism ; Female ; Humans ; Immunohistochemistry ; Lung Neoplasms ; metabolism ; pathology ; Stomach Neoplasms ; metabolism ; pathology
5.Nipple adenoma: report of 18 cases with review of literatures.
Guang-zhi YANG ; Jing LI ; Hua-ye DING
Chinese Journal of Pathology 2009;38(9):614-616
OBJECTIVETo investigate the clinicopathological and immunohistochemical features, diagnosis and differential diagnosis of nipple adenoma of the breast.
METHODSMorphological observation and immunohistochemistry were applied to 18 cases of nipple adenoma with a review of the related literatures.
RESULTSThe neoplasms were localized at nipples or under the areola of breast, adherent to the epidermis, mainly composed of dilated ducts in a tubular appearance associated with fibrotic matrix. The glandular epithelium showed various type of proliferation, forming thick layers or complex structures such as papillae, micropapillae, tufts, fronds, arcades or bridges accompanying with solid or cribriform cell nests. The tumor cells were crowding, lack of an uniform morphology and polarity with intact myoepithelial cells around the ducts. By immunostaining, the glandular epithelium was diffusely positive for 34betaE12, patchily positive for CK5/6, and negative for p53 and c-erbB-2. The myoepithelium, positive for p63, smooth muscle actin and Calponin, was well preserved and outlining the ducts.
CONCLUSIONSNipple adenoma is an infrequent type of benign breast neoplasm, presenting as sclerosing papilloma, papillomatosis or florid sclerosing adenosis. It is easily confused with atypical ductal hyperplasia/low grade ductal carcinoma in situ, invasive ductal carcinoma or low grade adenosquamous carcinoma. A correct diagnosis is based on the peculiar location and morphology of the tumor, and immunohistochemistry is helpful in some cases.
Adenoma ; metabolism ; pathology ; surgery ; Adult ; Breast Neoplasms ; metabolism ; pathology ; surgery ; Carcinoma in Situ ; metabolism ; pathology ; Carcinoma, Adenosquamous ; metabolism ; pathology ; Carcinoma, Ductal, Breast ; metabolism ; pathology ; Diagnosis, Differential ; Female ; Humans ; Keratin-5 ; metabolism ; Keratins ; metabolism ; Middle Aged ; Nipples ; metabolism ; pathology ; surgery
6.Variations of the amount of sialic acids on hepatocellular carcinoma cell membrane.
Zu-yuan GONG ; Cai-xian LIAO ; Yu WANG ; Xin-xin LIAO ; An-cheng QIN ; Yong-ping HUANG ; Hui LIAO
Journal of Southern Medical University 2010;30(10):2323-2326
OBJECTIVETo observe the change in the amount of sialic acids on hepatocellular carcinoma (HCC) cell membrane.
METHODSSurgical specimens of HCC and liver cirrhosis tissues were obtained from 28 patients to prepare carcinoma cell and hepatocyte suspensions by collagenase digestion. For assay of α2, 3 and α2, 6-sialic acids, the cells were suspended in the staining buffer containing either fluorescein isothiocyanate-Maackia amurensis lectin (FITC-MAL) or fluorescein isothiocyanate-Sambucus nigra bark lectin (FITC-SNA) and incubated for 1 h, respectively. Flow cytometric analysis was carried out to measure the mean fluorescence intensity (MFI) on the cell surface.
RESULTSIn both FITC-MAL- and FITC-SNA-incubated HCC cells, the MFI on the cell surface was greater than that of the hepatocytes.
CONCLUSIONBoth of α2, 3 and α2, 6- sialic acids increases significantly on the hepatocyte membrane after the carcinomatous change.
Carcinoma, Hepatocellular ; metabolism ; pathology ; Cell Membrane ; metabolism ; Humans ; Liver Cirrhosis ; metabolism ; pathology ; Liver Neoplasms ; metabolism ; pathology ; Sialic Acids ; metabolism
8.Neuroendocrine differentiation in prostate cancer.
Cheng-yu WU ; Yan-qun NA ; Jorge L YAO ; P Anthony di SANT'AGNESE ; Jiao-ti HUANG
Chinese Journal of Pathology 2006;35(9):565-567
Animals
;
Carcinoma, Neuroendocrine
;
metabolism
;
pathology
;
physiopathology
;
Carcinoma, Small Cell
;
metabolism
;
pathology
;
physiopathology
;
Cell Differentiation
;
Chromogranin A
;
metabolism
;
Humans
;
Male
;
Neuroendocrine Cells
;
metabolism
;
pathology
;
Prostatic Neoplasms
;
metabolism
;
pathology
;
physiopathology
9.The expression and clinical significance of EphA2 and E-cadherin in papillary thyroid carcinoma.
Yan LIU ; Yuhua MIAO ; Xiaoming LI
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(11):1020-1023
OBJECTIVE:
To investigate the expression and clinical significance of EphA2 and E cadherin proteins in papillary thyroid carcinoma tissues, and to explore the relationship between them.
METHOD:
Using immunohistochemical SP/PV method, we detected the expression of EphA2 and E cadherin in tumors of 43 papillary thyroid carcinomas, 11 thyroid adenoma and 10 normal thyroid tissues, then studied their relationships with clinic pathological factors.
RESULT:
The total positive rates of EphA2 and E cadherin expression were 58. 14% and 32. 56% in papillary thyroid carcinoma tissues, 18. 18% and 81. 81% in thyroid adenoma.tissues and they were 10. 00% and 100. 00% in normal thyroid tissues respectively. The positive expression of EphA2 in carcinoma tissues was higher than in the thyroid adenoma tissues and normal thyroid tissues (P<0. 05) and the positive expression of E cadherin in carcinoma tissues was lower than that in the thyroid adenoma tissues and normal thyroid tissues (P<0. 05). The positive expression of EphA2 and E cadherin was associated with lymph node metastasis and histological grade (P<0. 05), but it was not associated with all the clinic-pathological factors including age, sex and the tumor size (P>0. 05). In papillary thyroid carcinoma tissues, the expression of EphA2 was negatively correlated with the expression of E cadherin protein (r= -0. 416, P<0. 01).
CONCLUSION
EphA2 and E cadherin may be involved in carcinogenesis and development of papillary thyroid carcinoma.
Adenoma
;
metabolism
;
pathology
;
Antigens, CD
;
Cadherins
;
metabolism
;
Carcinoma
;
metabolism
;
pathology
;
Carcinoma, Papillary
;
Humans
;
Lymphatic Metastasis
;
Receptor, EphA2
;
metabolism
;
Thyroid Cancer, Papillary
;
Thyroid Gland
;
metabolism
;
Thyroid Neoplasms
;
metabolism
;
pathology
10.Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case.
Chinese Journal of Pathology 2010;39(1):54-55
Adenocarcinoma, Mucinous
;
pathology
;
Adult
;
Breast Neoplasms
;
metabolism
;
pathology
;
surgery
;
Carcinoma
;
pathology
;
Carcinoma in Situ
;
metabolism
;
pathology
;
surgery
;
Carcinoma, Ductal, Breast
;
metabolism
;
pathology
;
surgery
;
Diagnosis, Differential
;
Female
;
Fibrocystic Breast Disease
;
metabolism
;
pathology
;
surgery
;
Humans
;
Hyperplasia
;
Lactalbumin
;
metabolism
;
S100 Proteins
;
metabolism